ANGO vs BK · rev $292.5M vs P/E 17, rev $20.08B
AngioDynamics Inc (ANGO) versus The Bank of New York Mellon Corporation (BK) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
The Bank of New York Mellon Corporation (BK) is a banks - diversified company listed on US.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported BK revenue for 2025-12-31 was $20.08B. Net income was $5.55B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. BK currently screens at market cap $94.14B and trailing P/E 17.0.
ANGO currently screens at market cap $378.5M. BK currently screens at market cap $94.14B and trailing P/E 17.0.
Not investment advice. Open the ANGO and BK stock pages for the full models.
Not investment advice.